Previous studies have shown that MFAP2 was involved in controlling growth factor signal transduction and interacted with the TGF‐β superfamily members to promote tumour progression, particularly in relation to epithelial‐mesenchymal transition (EMT) and ECM remodelling.9, 30, 31, 32. This evidence concerns the gene MFAP2 and neoplasm.